Part 3: Understanding the manufacturing of unproven cellular therapy products.

Eldridge, Paul; Griffin, Deborah; Janssen, William; O'Donnell, Lynn

Eldridge, Paul; Griffin, Deborah; Janssen, William; O'Donnell, Lynn.

Afiliación

Eldridge P; University of North Carolina Lineberger Comprehensive Cancer Center, Advanced Cellular Therapeutics Facility, Chapel Hill, North Carolina, USA. ISCT North America, Past Regional Vice President 2012-2014. Electronic address: paul.eldridge@med.unc.edu.
Griffin D; Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Chair, ISCT NA LRA Committee, 2014-2016 and Co-Editor of the Telegraft.
Janssen W; St Jude Children's Research Hospital, Memphis, Tennessee, USA. ISCT Past Co-Chair, NA LRA Committee 2011-2014. ISCT North America, Regional Vice President 2014-2016.
O'Donnell L; Division of Hematology, Cell Therapy Laboratory, The Ohio State University, Columbus, Ohio, USA. ISCT Global Secretary, 2013-2016 and Editor in Chief of Telegraft.

Cytotherapy ; 18(1): 124-6, 2016 Jan.

Article en En | MEDLINE | ID: mdl-26719204

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google